Skip to main content
. 2019 Sep 18;14(9):e0221496. doi: 10.1371/journal.pone.0221496

Table 2. What is provided to participants/donors in respondents’ current IC procedures?

What information is provided to participants/donors in the IC procedure? Is provided in the IC Is not provided in the IC I don’t know
General info about the biobank and who is responsible for the IC procedure n 186 20 11
% 85.7% 9.2% 5.1%
Contact details of the biobank n 174 30 13
% 80.2% 13.8% 6.0%
The purpose and (future) objectives of the associated research n 191 16 8
% 88.8% 7.4% 3.7%
Details about research conducted through the biobank (e.g. via an online tool) n 72 124 16
% 34.0% 58.5% 7.5%
Possibility for the participant/donor to be re-contacted for additional data/samples n 135 66 13
% 63.1% 30.8% 6.1%
Possibility of returning individual research results n 129 68 14
% 61.1% 32.2% 6.6%
Linkage of data/samples with data from other sources (e.g. registries, national statistics) n 115 78 20
% 54.0% 36.6% 9.4%
Sharing data/samples with other non-commercial research partners n 165 33 18
% 76.4% 15.3% 8.3%
Sharing data/samples with commercial and/or health industry partners n 119 77 20
% 55.1% 35.6% 9.3%
Sharing data/samples with parties in other EU countries n 125 69 20
% 58.4% 32.2% 9.3%
Sharing data/samples with parties in non-EU countries n 110 82 23
% 51.2% 38.1% 10.7%
Expected storage period for data/samples n 119 81 13
% 55.9% 38.0% 6.1%
The right to withdraw IC at any time and what happens to data and samples afterwards n 192 13 9
% 89.7% 6.1% 4.2%
Other rights of participants, e.g. right to access data or right to know how data is processed n 118 75 20
% 55.4% 35.2% 9.4%
The right to lodge a complaint with a supervisory authority (e.g. an ethics commission), including contact info n 73 110 30
% 34.3% 51.6% 14.1%